Related by context. Frequent words. (Click for all words.) 70 Monoclonal Antibody 69 Elesclomol 69 Perifosine 69 Voreloxin 69 Clinical Trial Results 68 Ofatumumab 68 Cethromycin 68 Drug Candidate 68 Sym# 68 Bortezomib 67 humanized monoclonal antibody 67 Metastatic Melanoma 67 Linaclotide 67 BAL# [001] 67 orally bioavailable 66 Pivotal Phase 66 Carfilzomib 66 EZN 66 Chronic Hepatitis C 65 Pivotal Phase III 65 Phase III Clinical Trial 65 Phase III Trial 65 EGFr 65 proteasome inhibitors 65 OncoVEX GM CSF 65 humanized anti 65 Completes Enrollment 65 Irinotecan 65 Bevacizumab 65 HGS ETR1 64 Imprime PGG 64 Trastuzumab 64 Nexavar ® 64 Erlotinib 64 RGB # 64 TG# [001] 64 Monotherapy 64 MUC1 64 Immunogenicity 63 Small Molecule 63 Azedra 63 CYC# 63 Clevudine 63 Alemtuzumab 63 ALN VSP 63 CR# vcMMAE 63 Lenalidomide 63 Aurora kinase 62 Onalta 62 OXi# 62 Naproxcinod 62 nucleoside analogue 62 Initiates Phase 62 DAVANAT 62 drug conjugate 62 synthetic peptide 62 glioblastoma multiforme GBM 62 PARP inhibitor 62 BAY #-# 62 GV# [001] 62 tyrosine kinase inhibitor 62 Chronic Lymphocytic Leukemia 62 hypoxia inducible factor 62 PEGylated 62 angiogenesis inhibitor 62 potent inhibitor 62 therapeutic monoclonal antibodies 62 ANG# 62 Pivotal Trial 62 Ceftobiprole 62 IMC A# 62 metastatic hormone refractory 62 Gemcitabine 62 Pirfenidone 62 immunomodulator 62 pertuzumab 61 relapsed multiple myeloma 61 fusion inhibitor 61 Hepatitis C Virus 61 Apixaban 61 Panitumumab 61 Fidaxomicin 61 hepatitis C HCV 61 Crofelemer 61 Nimotuzumab 61 BMS # 61 immunomodulatory 61 Atiprimod 61 Antisense 61 #ME# 61 CA4P 61 SCH # 61 sphingosine 1 61 LY# [003] 61 HuMax CD# 61 Combination Therapy 60 immunotherapeutics 60 thymalfasin 60 Imatinib 60 nanoviricides 60 Tolerability